Announcements Trials
Browse Landscape

Phase

Phase 2 15Phase 1 12Phase 1/2 4Phase NA 2Phase 3 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Breast Neoplasms 427Neoplasms 376Prostatic Neoplasms 205Lung Neoplasms 194Colorectal Neoplasms 148Motor Activity 93Uterine Cervical Neoplasms 80Pancreatic Neoplasms 78Carcinoma, Non-Small-Cell Lung 75Head and Neck Neoplasms 72Brain Neoplasms 71Ovarian Neoplasms 62Carcinoma, Hepatocellular 54Rectal Neoplasms 49Neoplasm Metastasis 49Colonic Neoplasms 47Anxiety Disorders 47Precursor Cell Lymphoblastic Leukemia-Lymphoma 46Depression 42Hematologic Neoplasms 41Glioblastoma 39Melanoma 37Disease 37Glioma 36Stomach Neoplasms 35Sarcoma 34Multiple Myeloma 34Lymphoma 32Pain 31Gastrointestinal Neoplasms 31

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Ependymoma × 90 days × Clear all
NCT03033992 2026-06-02

Optune for Children With High-Grade Glioma or Ependymoma, and Optune With Radiation Therapy for Children With DIPG

Children's Oncology Group

Phase NA Active not recruiting
80 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Ependymoma, Glioma

NCT05057702 2026-04-15

PNOC027

University of California, San Francisco

Phase NA Recruiting
74 enrolled
CNS

Ependymoma, Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡